1. Home
  2. INZY vs FLNT Comparison

INZY vs FLNT Comparison

Compare INZY & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • FLNT
  • Stock Information
  • Founded
  • INZY 2015
  • FLNT 2001
  • Country
  • INZY United States
  • FLNT United States
  • Employees
  • INZY N/A
  • FLNT N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • FLNT Advertising
  • Sector
  • INZY Health Care
  • FLNT Consumer Discretionary
  • Exchange
  • INZY Nasdaq
  • FLNT Nasdaq
  • Market Cap
  • INZY 64.9M
  • FLNT 54.9M
  • IPO Year
  • INZY 2020
  • FLNT N/A
  • Fundamental
  • Price
  • INZY $1.15
  • FLNT $2.32
  • Analyst Decision
  • INZY Strong Buy
  • FLNT Hold
  • Analyst Count
  • INZY 9
  • FLNT 1
  • Target Price
  • INZY $17.22
  • FLNT $3.50
  • AVG Volume (30 Days)
  • INZY 1.1M
  • FLNT 15.0K
  • Earning Date
  • INZY 05-20-2025
  • FLNT 05-16-2025
  • Dividend Yield
  • INZY N/A
  • FLNT N/A
  • EPS Growth
  • INZY N/A
  • FLNT N/A
  • EPS
  • INZY N/A
  • FLNT N/A
  • Revenue
  • INZY N/A
  • FLNT $254,623,000.00
  • Revenue This Year
  • INZY N/A
  • FLNT $9.20
  • Revenue Next Year
  • INZY N/A
  • FLNT $8.67
  • P/E Ratio
  • INZY N/A
  • FLNT N/A
  • Revenue Growth
  • INZY N/A
  • FLNT N/A
  • 52 Week Low
  • INZY $0.72
  • FLNT $2.01
  • 52 Week High
  • INZY $6.24
  • FLNT $4.30
  • Technical
  • Relative Strength Index (RSI)
  • INZY 50.96
  • FLNT 48.01
  • Support Level
  • INZY $1.18
  • FLNT $2.15
  • Resistance Level
  • INZY $1.63
  • FLNT $2.65
  • Average True Range (ATR)
  • INZY 0.20
  • FLNT 0.25
  • MACD
  • INZY 0.02
  • FLNT -0.01
  • Stochastic Oscillator
  • INZY 23.66
  • FLNT 30.91

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

Share on Social Networks: